Fig. 2

Phase contrast microscopic analysis of extracts treated HepG2 and HT-29 cell lines. A HepG2 cell line treated with 0.1% DMSO. B HepG2 cell line treated with 0.22 mg/mL root extract. C HepG2 cell line treated with 0.30 stem extract. D HT-29 cell line treated with 0.1% DMSO. E HT-29 cell line treated with 1.13 mg/mL root extract. F HT-29 cell line treated with 1.50 mg/mL stem extract